p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population

Cancer Investigation

Volumn 26, Issue 1, 2008, Pages 41-46

  Sreeja, Leelakumari ^a   Syamala, Vani ^a   Raveendran, Praveenkumar B ^a   Santhi, Sarojam ^a   Madhavan, Jayaprakash ^a   Ankathil, Ravindran ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

Lung Cancer; P53; Prognosis; Susceptibility

Indexed keywords

PROTEIN P53;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; INDIA; KAPLAN MEIER METHOD; LUNG CARCINOGENESIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37849054090     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701638459     Document Type: Article

References (28)

1. Vogelstein, B.; Kinzler, K.W. p53 function and dysfunction. Cell 1992, 70, 523-526.
2. Dumont, P.; Leu, J. I.; Della, P.A., III; George, D.L.; Murphy, M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003, 33, 357-365.
3. Birgander, R.; Sjalander, A.; Rannug, A.; Alexandrie, A.K.; Sundberg, M.I.; Seidegard, J.; Tornling, G.; Beckman, G.; Beckman, L. P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 1995, 16, 2233-2236.
4. Sjalander, A.; Birgander, R.; Hallmans, G.; Cajander, S.; Lenner, P.; Athlin, L.; Beckman, G.; Beckman, L. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 1996, 17, 1313-1316.
5. Rosenthal, A.N.; Ryan, A.; Al Jehani, R.M.; Storey, A.; Harwood, C.A.; Jacobs, I.J. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 1998, 352, 871-872.
6. Weston, A.; Perrin, L.S.; Forrester, K.; Hoover, R.N.; Trump, B.F.; Harris, C.C.; Caporaso, N.E. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol. Biomarkers Prev. 1992, 1, 481-483.
7. Kawajiri, K.; Nakachi, K.; Imai, K.; Watanabe, J.; Hayashi, S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 1993, 14, 1085-1089.
8. Jin, X.; Wu, X.; Roth, J.A.; Amos, C.I.; King, T.M.; Branch, C.; Honn, S.E.; Spitz, M.R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 1995, 16, 2205-2208.
9. Liu, G.; Miller, D.P.; Zhou, W.; Thurston, S.W.; Fan, R.; Xu, L.L.; Lynch, T.J.; Wain, J.C.; Su, L.; Christiani, D.C. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res. 2001, 61, 8718-8722.
10. Wu, X.; Zhao, H.; Amos, C.I.; Shete, S.; Makan, N.; Hong, W.K.; Kadlubar, F.F.; Spitz, M.R. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J. Natl. Cancer Inst. 2002, 94, 681-690.
11. Sambrook, J.; Frustaci, S.; Maniatis. Molecular Cloning A Laboratory Manual 2nd edition Cold Spring Harbor Laboratory Press Cold Spring Harbor NY, 1989.
12. Ara, S.; Lee, P.S.; Hansen, M.F.; Saya, H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res. 1990, 18, 4961.
13. Sreeja, L.; Syamala, V.; Hariharan, S.; Madhavan, J.; Devan, S.C.; Ankathil, R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J. Hum. Genet. 2005, 50, 618-627.
14. Baptiste, N.; Prives, C. p53 in the cytoplasm: a question of overkill? Cell 2004, 116, 487-489.
15. Fan, R.; Wu, M.T.; Miller, D.; Wain, J.C.; Kelsey, K.T.; Wiencke, J.K.; Christiani, D.C. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 1037-1042.
16. Irarrazabal, C.E.; Rojas, C.; Aracena, R.; Marquez, C.; Gil, L. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol. Lett. 2003, 144, 69-76.
17. Zhang, J.H,.; Li, Y.; Wang, R.; Wen, D.G.; Wu, M.L.; He, M. p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population. Zhonghua Zhong Liu Za Zhi. 2003, 25(4):365-367
18. Mechanic, L.E.; Marrogi, A.J.; Welsh, J.A.; Bowman, E.D.; Khan, M.A.; Enewold, L.; Zheng, Y.L.; Chanock, S.; Shields, P.G.; Harris, C.C. Polymorphisms in XPD and TP53 andmutation in human lung cancer. Carcinogenesis 2005, 26, 597-604.
19. Sakiyama, T.; Kohno, T.; Mimaki, S.; Ohta, T.; Yanagitani, N.; Sobue, T.; Kunitoh, H.; Saito, R.; Shimizu, K.; Hirama, C.; Kimura, J.; Maeno, G.; Hirose, H.; Eguchi, T.; Saito, D.; Ohki, M.; Yokota, J. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int. J. Cancer 2005, 114, 730-737.
20. Hu, Y.; McDermott, M.P.; Ahrendt, S.A. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Clin. Cancer Res. 2005, 11, 2502-2509.
21. Szymanowska, A.; Jassem, E.; Dziadziuszko, R.; Borg, A.; Limon, J.; Kobierska-Gulida, G.; Rzyman, W.; Jassem, J. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 2006, 52, 9-14.
22. Papadakis, E.D.; Soulitzis, N.; Spandidos, D.A. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br. J. Cancer 2002, 87, 1013-1018.
23. Jain, N.; Singh, V.; Hedau, S.; Kumar, S.; Daga, M.K.; Dewan, R.; Murthy, N.S.; Husain, S.A.; Das, B.C. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005, 128, 3999-4007.
24. Toyooka, S.; Tsuda, T.; Gazdar, A.F. The TP53 gene, tobacco exposure, and lung cancer. Hum. Mutat. 2003, 21, 229-239.
25. Wang, Y.C.; Lee, H.S.; Chen, S.K.; Chang, Y.Y.; Chen, C.Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur. J. Cancer 1999, 35, 226-230.
26. Wang, Y.C.; Chen, C.Y.; Chen, S.K.; Chang, Y.Y.; Lin, P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin. Cancer Res. 1999, 5, 129-134.
27. Nelson, H.H.; Wilkojmen, M.; Marsit, C.J.; Kelsey, K.T. TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis 2005, 26, 1770-1773.
28. Marin, M.C.; Jost, C.A.; Brooks, L.A.; Irwin, M.S.; O'Nions, J.; Tidy, J.A.; James, N.; McGregor, J. M.; Harwood, C.A.; Yulug, I.G.; Vousden, K.H.; Allday, M. J.; Gusterson, B.; Ikawa, S.; Hinds, P.W.; Crook, T.; Kaelin, W.G., Jr. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 2000, 25, 47-54.